Dear Colleagues,

This is to announce that after four great years, I will resign my positions as the President and CEO of CURE and President of The CURE Innovation Commons, effective October 1, 2017.

After giving the matter careful consideration, I feel that this is the right time for me to be moving on to other projects that will engage the same level of passion and community building that we at CURE have been fostering. I look forward to the challenges ahead.

But what an honor and pleasure it has been to work with so many friends and professionals on the CURE Team, the CURE Board of Directors, at Yale, UConn, Jackson Labs, Connecticut Innovations, CTNext, the Connecticut Technology Council, Crossroads Venture Group, the Connecticut Women’s Hall of Fame, the Connecticut Department of Economic and Community Development, and the over 200 other CURE members.

Every day these past four years I’ve had the privilege of encountering Connecticut’s growing presence in bioscience and healthcare. I’ve worked first hand with our developing pipeline of assets: a rich talent pool, commercially-valuable science and intellectual property, engaged faculty, experts and entrepreneurs, an impressive armamentarium of funding, incubators, and accelerators. I am particularly proud to say that later this month in San Diego, Connecticut will have a very substantial Pavilion at this year’s BIO International Convention.

Together we have created a very strong network, an environment of spark, partnership, and teamwork. Come hear more about our progress at the CURE Annual Meeting and celebratory picnic at The Commons in Groton on June 13!

I expect to see you there and around the Connecticut entrepreneurial ecosystem.